A CLINICAL STAGE BIOTECH COMPANY DEVELOPING PATIENT FOCUSED PROPRIETARY COMPOUNDS TO IMPROVE MENTAL HEALTH
LOBE SCIENCE is a clinical stage drug development biotechnology company focused on transforming psychedelic medicine to benefit patients of all ages.
We are engaged in research and development using proprietary and patent pending derivatives of psychedelic compounds delivered in a way that will not induce a psychedelic trip. We call our initial compounds L-130 and L-131
We believe that treating patients in their HOME with easily administered, transformational medicines is the appropriate path to creating a global pharmaceutical marketplace that benefits all patients and allows them to be cared for by their personal physician.
Our team of biotech executives, collectively, have managed the development and regulatory approval of revolutionary drugs around the globe.
To develop and deliver transformative therapeutic solutions to treat and potentially cure brain and mental health disease.